Lashen AG, Toss M, Miligy I, Rewcastle E, et al. Nottingham prognostic x (NPx): a risk stratification tool in ER-positive HER2-negative breast cancer: a validation study. Histopathology 2024 Jun 13. doi: 10.1111/his.15234.
PMID: 38867570